C

CNS Pharmaceuticals
D

CNSP

0.11350
USD
-0.00
(-0.35%)
Market Closed
Volume
63,607
EPS
-1
Div Yield
-
P/E
-0
Market Cap
6,524,741
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    177.08 USD
    AZN
    AZN
    -1.830
    (-2.81%)
    66.385 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.205 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    26.16 USD
    T
    TTOO
    -0.00300
    (-0.57%)
    0.52000 USD
    More
News

Title: CNS Pharmaceuticals Inc

Sector: Healthcare
Industry: Biotechnology
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.